A Comparison of the Safety and Comfort of AC-170

Completed · Phase 1

Conditions studied: Normal Ocular Health

In brief

The purpose of this study is to evaluate the safety and comfort of AC-170 compared to a placebo.

Key facts

Study ID

NCT01495338

Run by

Aciex Therapeutics, Inc.

People needed

60

Starts

2011-12-01

Expected to finish

2011-12-01

Last updated by the study team

2017-09-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Able and willing to avoid the use of ocular medications or topical ocular preparations within protocol specific time period.

You may not qualify if…

• Known contraindications or sensitivities to the study medication or its components.
• Any ocular condition that, in the opinion of the investigator, could affect the subjects safety or trial parameters.
• Use of disallowed medications during the period indicated prior to the study enrollment or during the study.

Where it is running

• Andover Eye Associates — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.